Yanli He
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Causal effect of gut microbiota on the risk of cancer and potential mediation by inflammatory proteins.
Journal: World journal of surgical oncology
Published: December 19, 2024
TIMM9 as a prognostic biomarker in multiple cancers and its associated biological processes.
Journal: Scientific reports
Published: April 11, 2024
Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation.
Journal: Journal of ethnopharmacology
Published: December 07, 2021
CSE1L silencing impairs tumor progression via MET/STAT3/PD-L1 signaling in lung cancer.
Journal: American journal of cancer research
Published: March 19, 2021
Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma.
Journal: Drug design, development and therapy
Published: June 18, 2020
Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways.
Journal: Anatomical record (Hoboken, N.J. : 2007)
Published: October 21, 2018
P-selectin-mediated LOX expression promotes insulinoma growth in Rip1-Tag2 mice by increasing tissue stiffness.
Journal: International journal of biological sciences
Published: June 07, 2016
Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer.
Journal: Oncotarget
Published: October 15, 2015
MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.
Journal: Scientific reports
Published: March 03, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026